Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1992 Dec;55(12):1200–1202. doi: 10.1136/jnnp.55.12.1200

A further British case of growth hormone induced Creutzfeldt-Jakob disease.

C J Ellis 1, H Katifi 1, R O Weller 1
PMCID: PMC1015340  PMID: 1479400

Abstract

Transmission of Creutzfeldt-Jakob disease (CJD) from cadaveric growth hormone injections had previously been reported in 7 cases, including one from Britain. As a result, the treatment was abandoned in 1985 and superceded by safer recombinant DNA growth hormone injections. Recent reports now record the number of cases worldwide as 23, but with the incubation period being measured in years, new cases of CJD can still present. We give a detailed report of one of the recent cluster of British cases and aim to highlight the problem to clinicians who may encounter further patients with cadaveric growth hormone induced CJD.

Full text

PDF
1200

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billette de Villemeur T. B., Beauvais P., Gourmelen M., Richardet J. M. Creutzfeldt-Jakob disease in children treated with growth hormone. Lancet. 1991 Apr 6;337(8745):864–865. doi: 10.1016/0140-6736(91)92583-n. [DOI] [PubMed] [Google Scholar]
  2. Brown P. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts. Pediatrics. 1988 Jan;81(1):85–92. [PubMed] [Google Scholar]
  3. Brown P., Preece M. A., Will R. G. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet. 1992 Jul 4;340(8810):24–27. doi: 10.1016/0140-6736(92)92431-e. [DOI] [PubMed] [Google Scholar]
  4. Brown P. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy. Neurology. 1988 Jul;38(7):1135–1137. doi: 10.1212/wnl.38.7.1135. [DOI] [PubMed] [Google Scholar]
  5. Buchanan C. R., Preece M. A., Milner R. D. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BMJ. 1991 Apr 6;302(6780):824–828. doi: 10.1136/bmj.302.6780.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Collinge J., Palmer M. S., Dryden A. J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991 Jun 15;337(8755):1441–1442. doi: 10.1016/0140-6736(91)93128-v. [DOI] [PubMed] [Google Scholar]
  7. Jones R. L., Benker G., Salacinski P. R., Lloyd T. J., Lowry P. J. Large-scale preparation of highly purified pyrogen-free human growth hormone for clinical use. J Endocrinol. 1979 Jul;82(1):77–86. doi: 10.1677/joe.0.0820077. [DOI] [PubMed] [Google Scholar]
  8. Knight R. Creutzfeldt-Jakob disease. Br J Hosp Med. 1989 Feb;41(2):165-6, 168-71. [PubMed] [Google Scholar]
  9. Macario M. E., Vaisman M., Buescu A., Moura Neto V., Araujo H. M., Chagas C. Pituitary growth hormone and Creutzfeldt-Jakob disease. BMJ. 1991 May 11;302(6785):1149–1149. doi: 10.1136/bmj.302.6785.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mills J. B., Ashworth R. B., Wilhelmi A. E., Hartree A. S. Improved method for the extraction and purification of human growth hormone. J Clin Endocrinol Metab. 1969 Nov;29(11):1456–1459. doi: 10.1210/jcem-29-11-1456. [DOI] [PubMed] [Google Scholar]
  11. Milner R. D. Growth hormone 1985. Br Med J (Clin Res Ed) 1985 Dec 7;291(6509):1593–1594. doi: 10.1136/bmj.291.6509.1593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Powell-Jackson J., Weller R. O., Kennedy P., Preece M. A., Whitcombe E. M., Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet. 1985 Aug 3;2(8449):244–246. doi: 10.1016/s0140-6736(85)90292-2. [DOI] [PubMed] [Google Scholar]
  13. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Committee on Health Care Issues, American Neurological Association. Ann Neurol. 1986 Jan;19(1):75–77. doi: 10.1002/ana.410190113. [DOI] [PubMed] [Google Scholar]
  14. Preece M. A. Creutzfeldt-Jakob disease: implications for growth hormone deficient children. Neuropathol Appl Neurobiol. 1986 Sep-Oct;12(5):509–515. doi: 10.1111/j.1365-2990.1986.tb00061.x. [DOI] [PubMed] [Google Scholar]
  15. Taylor D. M., Dickinson A. G., Fraser H., Robertson P. A., Salacinski P. R., Lowry P. J. Preparation of growth hormone free from contamination with unconventional slow viruses. Lancet. 1985 Aug 3;2(8449):260–262. doi: 10.1016/s0140-6736(85)90302-2. [DOI] [PubMed] [Google Scholar]
  16. Weller R. O. Iatrogenic transmission of Creutzfeldt-Jakob disease. Psychol Med. 1989 Feb;19(1):1–4. doi: 10.1017/s0033291700010965. [DOI] [PubMed] [Google Scholar]
  17. Weller R. O., Steart P. V., Powell-Jackson J. D. Pathology of Creutzfeldt-Jakob disease associated with pituitary-derived human growth hormone administration. Neuropathol Appl Neurobiol. 1986 Mar-Apr;12(2):117–129. doi: 10.1111/j.1365-2990.1986.tb00045.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES